A carregar...

Degarelix and its therapeutic potential in the treatment of prostate cancer

Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist for the treatment of patients with prostate cancer in whom hormonal therapy is indicated. Two phase II trials and one phase III have been published as full papers in the literature. In the dose-finding phase II studies an initial dose o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Doehn, Christian, Sommerauer, Martin, Jocham, Dieter
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2685243/
https://ncbi.nlm.nih.gov/pubmed/19503784
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!